February 13, 2025 - 06:04

L3Harris Technologies has made significant strides in enhancing the capabilities of the United States' torpedo systems. The company has developed advanced technologies that improve the performance and reliability of torpedoes, ensuring that they meet the evolving demands of modern naval warfare.
These enhancements include upgraded guidance systems, which increase accuracy and target acquisition speed, allowing for more effective engagement with enemy submarines and surface vessels. Additionally, L3Harris is focusing on integrating cutting-edge sensor technology that enhances situational awareness and threat detection, providing a tactical advantage in underwater combat scenarios.
The advancements in torpedo technology come at a crucial time when naval forces are seeking to bolster their underwater capabilities in response to increasing global maritime threats. By leveraging innovative engineering and robust testing protocols, L3Harris aims to ensure that the US Navy remains at the forefront of underwater warfare technology. This commitment not only strengthens national defense but also reinforces the strategic deterrence posture of the United States on the global stage.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...